We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Critical services will be better safeguarded, thanks to £155 million government investment to boost national security and deliver national renewal.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Over 100 mobile network masts upgraded to deliver 4G coverage from all major mobile network operators, signalling a major milestone in government’s drive to end total-not-spots
Benefit-Risk Submission Report (BRSR) and Pharmacovigilance Sales Submission (PSS) templates and guidance for completion of BRSRs, PSSs and signal notifications.
Statistics showing the number of signals passed at danger (SPADs) without authority in each quarter since 1998 to 1999 (quarter 4) in Great Britain.
Statistics showing the number of signals passed at danger (SPADs) without authority.
Guidance covering various aspects of pharmacovigilance for authorised and unauthorised medicinal products (Specials and the Early Access to Medicines Scheme (EAMS)).
How to write clear and effective field safety notices (FSNs) for medical devices.
10 Use Cases
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).